<code id='034AC43F9B'></code><style id='034AC43F9B'></style>
    • <acronym id='034AC43F9B'></acronym>
      <center id='034AC43F9B'><center id='034AC43F9B'><tfoot id='034AC43F9B'></tfoot></center><abbr id='034AC43F9B'><dir id='034AC43F9B'><tfoot id='034AC43F9B'></tfoot><noframes id='034AC43F9B'>

    • <optgroup id='034AC43F9B'><strike id='034AC43F9B'><sup id='034AC43F9B'></sup></strike><code id='034AC43F9B'></code></optgroup>
        1. <b id='034AC43F9B'><label id='034AC43F9B'><select id='034AC43F9B'><dt id='034AC43F9B'><span id='034AC43F9B'></span></dt></select></label></b><u id='034AC43F9B'></u>
          <i id='034AC43F9B'><strike id='034AC43F9B'><tt id='034AC43F9B'><pre id='034AC43F9B'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:82
          A display of TVs against an orange background. -- health policy coverage from STAT
          Adobe

          WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

          White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

          advertisement

          Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Generate Biomedicines machine learning biotech raises $273M
          Generate Biomedicines machine learning biotech raises $273M

          AdobeBiotechstartupGenerateBiomedicines,whichusesartificialintelligencetofindnewdrugs,raised$273mill

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Acelyrin, a rare IPO success, stumbles in its first big test

          MarkLennihan/APThebiotechcompanyAcelyrin,whichraisedmorethan$500millioninanIPOthisyear,ranintoitsfir